Automated Cell Cultures Market Report 2025

This automated cell cultures market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The automated cell cultures market size has grown rapidly in recent years. It will grow from $6.33 billion in 2024 to $7.02 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to rising demand for high-throughput cell lines in drug discovery research, increasing investments in biopharmaceuticals and vaccine development, growing focus on stem cell research and development across various sectors, expanding applications of automated systems in laboratories to enhance efficiency and growing awareness of the benefits of automation in reducing human error and contamination.

The automated cell cultures market size is expected to see rapid growth in the next few years. It will grow to $10.49 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to the increasing number of clinical trials and research activities globally, the growing need for customized medications and personalized therapies, the rising prevalence of chronic diseases leading to higher demand for diagnostic tools, technological advancements in cell culture systems enhancing productivity and quality and increased government funding for cell-based research and biotechnology initiatives. Major trends in the forecast period include a shift towards modular automation solutions for flexibility in laboratory settings, the development of novel 3d cell culture techniques for improved cell behavior studies, the integration of artificial intelligence in automated cell culture processes, growing emphasis on sustainability and eco-friendly practices in cell culture technologies and expansion of automated systems in emerging markets due to rising healthcare investments.

The rising production of biopharmaceuticals is expected to drive the growth of the automated cell cultures market. Biopharmaceuticals, produced through biotechnology methods such as recombinant DNA technology and cell culture techniques, offer targeted and effective treatments with fewer side effects compared to traditional therapies. The increasing demand for these drugs is boosting the need for automated cell culture systems, which enhance the efficiency and consistency of biopharmaceutical production by streamlining cell growth, monitoring, and harvesting processes. For instance, the European Federation of Pharmaceutical Industries and Associations (EFPIA) reported in June 2023 that the total biopharmaceutical production in Europe reached $384.2 billion (€340 billion) in 2022, up about 4.95% from $366.3 billion (€324 billion) in 2021. This growth in biopharmaceutical production is fueling the demand for automated cell cultures.

Leading companies in the automated cell cultures market are focusing on technological advancements, such as AI-powered software, to gain a competitive edge. AI-integrated software in automated cell culture systems optimizes experimental conditions and enhances efficiency by analyzing real-time data to improve cell growth and productivity. For example, in October 2023, Molecular Devices LLC, a US-based biotechnology firm, introduced the CellXpress.ai Automated Cell Culture System. This innovative system aims to advance drug discovery by automating complex cell culture workflows, thereby increasing efficiency and reliability and allowing researchers to focus on more critical tasks.

In February 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, partnered with Celltrio Inc. to develop a fully automated cell culture system for biotherapeutics. This collaboration combines Thermo Fisher's Momentum software with Celltrio's RoboCell platform to achieve comprehensive automation in cell line culturing. Celltrio Inc., based in the US, specializes in automation solutions for biobanking and cell line development.

Major companies operating in the automated cell cultures market are Hitachi Ltd., Panasonic Holdings Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Kawasaki Heavy Industries Ltd, Lonza Group AG, Nikon healthcare, Sartorius AG, Beckman Coulter Inc., Celltrio Inc., Eppendorf AG, Tecan Trading AG, Shibuya Corp, Hamilton Company, Molecular Devices LLC, FORMULATRIX, Highres Biosolutions, HiMedia Laboratories, Biotron Healthcare.

North America was the largest region in the automated cell cultures market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated cell cultures market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automated cell cultures market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Automated cell cultures involve the use of automated systems and robotics to carry out cell culture tasks such as seeding, feeding, and harvesting. These systems minimize manual labor, enhance reproducibility, and improve the scalability of cell culture processes. Automation helps maintain sterile conditions and ensures consistent results.

The main types of automated cell cultures are modular automation and whole-system automation. Modular automation involves using integrated, pre- or post-analytical automation modules in laboratories to streamline workflows and boost efficiency. Equipment types include automated liquid handling systems, microplate readers, robotic systems, and automated storage and retrieval systems. Applications of automated cell cultures span biopharmaceutical production, diagnostics, gene therapy, drug screening and development, toxicity testing, stem cell research, tissue engineering and regenerative medicine, and personalized medicine. End users include pharmaceutical and biotechnology companies, hospital and diagnostic laboratories, research institutes, and cell banks.

The automated cell cultures market research report is one of a series of new reports that provides automated cell cultures market statistics, including automated cell cultures industry global market size, regional shares, competitors with a automated cell cultures market share, detailed automated cell cultures market segments, market trends and opportunities, and any further data you may need to thrive in the automated cell cultures industry. This automated cell cultures market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The automated cell cultures market consists of sales of automated bioreactors, cell culture platforms, and associated software for managing and analyzing cell growth and behavior. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.